Medical Care

Global Graves Disease Market Research Report 2025

The global market for Graves Disease was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Graves’ disease is an autoimmune disorder that stimulates the thyroid gland to release excessive thyroid hormone, leading to hyperthyroidism. It is termed as Basedow’s disease in continental Europe and Graves’ disease in the U.S. In this disease, body’s immune system produces antibodies that help the thyroid gland to grow which in turn synthesizes abnormal levels of thyroid hormones causing hyperthyroidism.
North American market for Graves Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Graves Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Graves Disease in Hospital Pharmacy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Graves Disease include Abbott Laboratories, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Graves Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Graves Disease.
The Graves Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Graves Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Graves Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
GlaxoSmithKline plc
Merck & Co
Pfizer, Inc
RLC LABS
AbbVie, Inc
Mylan N.V
Allergan, plc
Segment by Type
Anti-Thyroid Drugs
Lodine &Lodides
Radioactive Lodine
Lonic Inhibitors
Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Graves Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Graves Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anti-Thyroid Drugs
1.2.3 Lodine &Lodides
1.2.4 Radioactive Lodine
1.2.5 Lonic Inhibitors
1.3 Market by Application
1.3.1 Global Graves Disease Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Graves Disease Market Perspective (2020-2031)
2.2 Global Graves Disease Growth Trends by Region
2.2.1 Global Graves Disease Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Graves Disease Historic Market Size by Region (2020-2025)
2.2.3 Graves Disease Forecasted Market Size by Region (2026-2031)
2.3 Graves Disease Market Dynamics
2.3.1 Graves Disease Industry Trends
2.3.2 Graves Disease Market Drivers
2.3.3 Graves Disease Market Challenges
2.3.4 Graves Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Graves Disease Players by Revenue
3.1.1 Global Top Graves Disease Players by Revenue (2020-2025)
3.1.2 Global Graves Disease Revenue Market Share by Players (2020-2025)
3.2 Global Graves Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Graves Disease Revenue
3.4 Global Graves Disease Market Concentration Ratio
3.4.1 Global Graves Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Graves Disease Revenue in 2024
3.5 Global Key Players of Graves Disease Head office and Area Served
3.6 Global Key Players of Graves Disease, Product and Application
3.7 Global Key Players of Graves Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Graves Disease Breakdown Data by Type
4.1 Global Graves Disease Historic Market Size by Type (2020-2025)
4.2 Global Graves Disease Forecasted Market Size by Type (2026-2031)
5 Graves Disease Breakdown Data by Application
5.1 Global Graves Disease Historic Market Size by Application (2020-2025)
5.2 Global Graves Disease Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Graves Disease Market Size (2020-2031)
6.2 North America Graves Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Graves Disease Market Size by Country (2020-2025)
6.4 North America Graves Disease Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Graves Disease Market Size (2020-2031)
7.2 Europe Graves Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Graves Disease Market Size by Country (2020-2025)
7.4 Europe Graves Disease Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Graves Disease Market Size (2020-2031)
8.2 Asia-Pacific Graves Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Graves Disease Market Size by Region (2020-2025)
8.4 Asia-Pacific Graves Disease Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Graves Disease Market Size (2020-2031)
9.2 Latin America Graves Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Graves Disease Market Size by Country (2020-2025)
9.4 Latin America Graves Disease Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Graves Disease Market Size (2020-2031)
10.2 Middle East & Africa Graves Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Graves Disease Market Size by Country (2020-2025)
10.4 Middle East & Africa Graves Disease Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Graves Disease Introduction
11.1.4 Abbott Laboratories Revenue in Graves Disease Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Details
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Graves Disease Introduction
11.2.4 GlaxoSmithKline plc Revenue in Graves Disease Business (2020-2025)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Merck & Co
11.3.1 Merck & Co Company Details
11.3.2 Merck & Co Business Overview
11.3.3 Merck & Co Graves Disease Introduction
11.3.4 Merck & Co Revenue in Graves Disease Business (2020-2025)
11.3.5 Merck & Co Recent Development
11.4 Pfizer, Inc
11.4.1 Pfizer, Inc Company Details
11.4.2 Pfizer, Inc Business Overview
11.4.3 Pfizer, Inc Graves Disease Introduction
11.4.4 Pfizer, Inc Revenue in Graves Disease Business (2020-2025)
11.4.5 Pfizer, Inc Recent Development
11.5 RLC LABS
11.5.1 RLC LABS Company Details
11.5.2 RLC LABS Business Overview
11.5.3 RLC LABS Graves Disease Introduction
11.5.4 RLC LABS Revenue in Graves Disease Business (2020-2025)
11.5.5 RLC LABS Recent Development
11.6 AbbVie, Inc
11.6.1 AbbVie, Inc Company Details
11.6.2 AbbVie, Inc Business Overview
11.6.3 AbbVie, Inc Graves Disease Introduction
11.6.4 AbbVie, Inc Revenue in Graves Disease Business (2020-2025)
11.6.5 AbbVie, Inc Recent Development
11.7 Mylan N.V
11.7.1 Mylan N.V Company Details
11.7.2 Mylan N.V Business Overview
11.7.3 Mylan N.V Graves Disease Introduction
11.7.4 Mylan N.V Revenue in Graves Disease Business (2020-2025)
11.7.5 Mylan N.V Recent Development
11.8 Allergan, plc
11.8.1 Allergan, plc Company Details
11.8.2 Allergan, plc Business Overview
11.8.3 Allergan, plc Graves Disease Introduction
11.8.4 Allergan, plc Revenue in Graves Disease Business (2020-2025)
11.8.5 Allergan, plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Graves Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Anti-Thyroid Drugs
Table 3. Key Players of Lodine &Lodides
Table 4. Key Players of Radioactive Lodine
Table 5. Key Players of Lonic Inhibitors
Table 6. Global Graves Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Graves Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Graves Disease Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Graves Disease Market Share by Region (2020-2025)
Table 10. Global Graves Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Graves Disease Market Share by Region (2026-2031)
Table 12. Graves Disease Market Trends
Table 13. Graves Disease Market Drivers
Table 14. Graves Disease Market Challenges
Table 15. Graves Disease Market Restraints
Table 16. Global Graves Disease Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Graves Disease Market Share by Players (2020-2025)
Table 18. Global Top Graves Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Graves Disease as of 2024)
Table 19. Ranking of Global Top Graves Disease Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Graves Disease Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Graves Disease, Headquarters and Area Served
Table 22. Global Key Players of Graves Disease, Product and Application
Table 23. Global Key Players of Graves Disease, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Graves Disease Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Graves Disease Revenue Market Share by Type (2020-2025)
Table 27. Global Graves Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Graves Disease Revenue Market Share by Type (2026-2031)
Table 29. Global Graves Disease Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Graves Disease Revenue Market Share by Application (2020-2025)
Table 31. Global Graves Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Graves Disease Revenue Market Share by Application (2026-2031)
Table 33. North America Graves Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Graves Disease Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Graves Disease Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Graves Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Graves Disease Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Graves Disease Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Graves Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Graves Disease Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Graves Disease Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Graves Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Graves Disease Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Graves Disease Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Graves Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Graves Disease Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Graves Disease Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Laboratories Company Details
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Graves Disease Product
Table 51. Abbott Laboratories Revenue in Graves Disease Business (2020-2025) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. GlaxoSmithKline plc Company Details
Table 54. GlaxoSmithKline plc Business Overview
Table 55. GlaxoSmithKline plc Graves Disease Product
Table 56. GlaxoSmithKline plc Revenue in Graves Disease Business (2020-2025) & (US$ Million)
Table 57. GlaxoSmithKline plc Recent Development
Table 58. Merck & Co Company Details
Table 59. Merck & Co Business Overview
Table 60. Merck & Co Graves Disease Product
Table 61. Merck & Co Revenue in Graves Disease Business (2020-2025) & (US$ Million)
Table 62. Merck & Co Recent Development
Table 63. Pfizer, Inc Company Details
Table 64. Pfizer, Inc Business Overview
Table 65. Pfizer, Inc Graves Disease Product
Table 66. Pfizer, Inc Revenue in Graves Disease Business (2020-2025) & (US$ Million)
Table 67. Pfizer, Inc Recent Development
Table 68. RLC LABS Company Details
Table 69. RLC LABS Business Overview
Table 70. RLC LABS Graves Disease Product
Table 71. RLC LABS Revenue in Graves Disease Business (2020-2025) & (US$ Million)
Table 72. RLC LABS Recent Development
Table 73. AbbVie, Inc Company Details
Table 74. AbbVie, Inc Business Overview
Table 75. AbbVie, Inc Graves Disease Product
Table 76. AbbVie, Inc Revenue in Graves Disease Business (2020-2025) & (US$ Million)
Table 77. AbbVie, Inc Recent Development
Table 78. Mylan N.V Company Details
Table 79. Mylan N.V Business Overview
Table 80. Mylan N.V Graves Disease Product
Table 81. Mylan N.V Revenue in Graves Disease Business (2020-2025) & (US$ Million)
Table 82. Mylan N.V Recent Development
Table 83. Allergan, plc Company Details
Table 84. Allergan, plc Business Overview
Table 85. Allergan, plc Graves Disease Product
Table 86. Allergan, plc Revenue in Graves Disease Business (2020-2025) & (US$ Million)
Table 87. Allergan, plc Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report


List of Figures
Figure 1. Graves Disease Picture
Figure 2. Global Graves Disease Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Graves Disease Market Share by Type: 2024 VS 2031
Figure 4. Anti-Thyroid Drugs Features
Figure 5. Lodine &Lodides Features
Figure 6. Radioactive Lodine Features
Figure 7. Lonic Inhibitors Features
Figure 8. Global Graves Disease Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Graves Disease Market Share by Application: 2024 VS 2031
Figure 10. Hospital Pharmacy Case Studies
Figure 11. Online Pharmacy Case Studies
Figure 12. Retail Pharmacy Case Studies
Figure 13. Graves Disease Report Years Considered
Figure 14. Global Graves Disease Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Graves Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Graves Disease Market Share by Region: 2024 VS 2031
Figure 17. Global Graves Disease Market Share by Players in 2024
Figure 18. Global Top Graves Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Graves Disease as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Graves Disease Revenue in 2024
Figure 20. North America Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Graves Disease Market Share by Country (2020-2031)
Figure 22. United States Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Graves Disease Market Share by Country (2020-2031)
Figure 26. Germany Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Graves Disease Market Share by Region (2020-2031)
Figure 34. China Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Graves Disease Market Share by Country (2020-2031)
Figure 42. Mexico Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Graves Disease Market Share by Country (2020-2031)
Figure 46. Turkey Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Graves Disease Business (2020-2025)
Figure 50. GlaxoSmithKline plc Revenue Growth Rate in Graves Disease Business (2020-2025)
Figure 51. Merck & Co Revenue Growth Rate in Graves Disease Business (2020-2025)
Figure 52. Pfizer, Inc Revenue Growth Rate in Graves Disease Business (2020-2025)
Figure 53. RLC LABS Revenue Growth Rate in Graves Disease Business (2020-2025)
Figure 54. AbbVie, Inc Revenue Growth Rate in Graves Disease Business (2020-2025)
Figure 55. Mylan N.V Revenue Growth Rate in Graves Disease Business (2020-2025)
Figure 56. Allergan, plc Revenue Growth Rate in Graves Disease Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies